Fight cancer: the Russian vaccine CaTeVac completes preclinical trials Deputy Prime Minister Tatiana Golikova announced a successful test of the dendritic cell vaccine CaTeVac, designed to stimulate the immune system against tumors. Its approval is in preparation, with the aim of applying from 2027 to sarcomas, melanoma and other complex cancers. Learn more about RT in French.
Fight cancer: the Russian vaccine CaTeVac completes preclinical trials Deputy Prime Minister Tatiana Golikova announced a successful test of the dendritic cell vaccine CaTeVac, designed to stimulate the immune system against tumors. Its approval is in preparation, with the aim of applying from 2027 to sarcomas, melanoma and other complex cancers. Learn more about RT in French.
🇷🇺 Russia · Map
More on Radar
Want to see every report in real time?
Hundreds of sources worldwide, translated into your language, with alerts for what matters to you.
Sign up free Already have an account? Log in